Exercise tolerance as a guide to clinical management of chronic heart failure: an individual approach
Patient no. 1 | Patient no. 2 | |
Peak VO2 (ml/kg per min) at baseline evaluation | 8 | 20 |
Laboratory peak VO2 variability; coefficient of variation | 4% | 4% |
Changes in peak VO2 (ml/kg per min) related to measurement variability | 0.3 | 0.8 |
Within-peak VO2 variability (ml/kg per min) | 7.7–8.3 | 19.2–20.8 |
Therapeutic efficacy (ml/kg per min) | >8.3 | >20.8 |
Warning decrease in peak VO2 (ml/kg per min) | <7.7 | <19.2 |
Patient no. 1 | Patient no. 2 | |
Peak VO2 (ml/kg per min) at baseline evaluation | 8 | 20 |
Laboratory peak VO2 variability; coefficient of variation | 4% | 4% |
Changes in peak VO2 (ml/kg per min) related to measurement variability | 0.3 | 0.8 |
Within-peak VO2 variability (ml/kg per min) | 7.7–8.3 | 19.2–20.8 |
Therapeutic efficacy (ml/kg per min) | >8.3 | >20.8 |
Warning decrease in peak VO2 (ml/kg per min) | <7.7 | <19.2 |
VO2, oxygen uptake.
Exercise tolerance as a guide to clinical management of chronic heart failure: an individual approach
Patient no. 1 | Patient no. 2 | |
Peak VO2 (ml/kg per min) at baseline evaluation | 8 | 20 |
Laboratory peak VO2 variability; coefficient of variation | 4% | 4% |
Changes in peak VO2 (ml/kg per min) related to measurement variability | 0.3 | 0.8 |
Within-peak VO2 variability (ml/kg per min) | 7.7–8.3 | 19.2–20.8 |
Therapeutic efficacy (ml/kg per min) | >8.3 | >20.8 |
Warning decrease in peak VO2 (ml/kg per min) | <7.7 | <19.2 |
Patient no. 1 | Patient no. 2 | |
Peak VO2 (ml/kg per min) at baseline evaluation | 8 | 20 |
Laboratory peak VO2 variability; coefficient of variation | 4% | 4% |
Changes in peak VO2 (ml/kg per min) related to measurement variability | 0.3 | 0.8 |
Within-peak VO2 variability (ml/kg per min) | 7.7–8.3 | 19.2–20.8 |
Therapeutic efficacy (ml/kg per min) | >8.3 | >20.8 |
Warning decrease in peak VO2 (ml/kg per min) | <7.7 | <19.2 |
VO2, oxygen uptake.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.